Vidvan Image

Dr PUGAZHENTHAN THANGARAJU

vidwan id: 196114
Male

Assistant Professor,
All India Institute of Medical Sciences (AIIMS), Raipur

Expertise

  • Pharmacology and Pharmacy

Publications

Total Articles 120
Books 0
Proceedings 0

Publications

No publication activity to display at the moment.

Scopus

Citations 19
h-index 2

CrossRef

CrossRef Icon
Citations 9
h-index 1
Google Scholar

Loading Scholar statistics...

Professional Recognition

2003

Tamilnadu Chief Minister Award during MBBS.

Government of Tamilnadu
2013

Statement of Accomplishment: Antimicrobial Stewardship: Optimization of Antibiotic Practices

Stanford University
2014

Statement of Accomplishment: Genes and the Human Condition (From Behaviour to Biotechnology)

University of Maryland
2016

DST SERB young scientist award of international travel grant

DST SERB GOI
2016

CICS international travel award

Tamilnadu CICS
2017

5th Academic Achievement Awards-17 as an official spotlight certificate award

EET CRS
2019

7th Academic Brilliance Awards- 2019 as Honorary Mention Jury under Award For Excellence In Research

EET CRS
2019

4th South Asian Education Awards 19 Official Spotlight Research

EET CRS
2020

Young Faculty Award in 8th Academic Brilliance Awards

EET CRS
2012

cleared UPSC Combined medical services

UNION PUBLIC SERVICE COMMISSION
2017

MEMBER OF NATIONAL ACADEMY OF MEDICAL SCIENCES

NATIONAL ACADEMY OF MEDICAL SCIENCES
2022

Proud Indian - Innovative Teacher Award 2022 in Infectious Disease

International Multidisciplinary Research Foundation

Community & Membership

2019

INSTITUTIONAL ANIMAL HOUSE FACILITY

MEMBER SECRETARY
2015

IAEC CLTRI

MEMBER
2014

IEC CLTRI

MEMBER SECRETARY
2020

TECHNICAL EVALUTION COMMITTE GOI

EXPERT MEMBER

International Multidisciplinary Research Foundation Leading Research Organization in India

2022
life member

world association of medical editors

2022
life member

 Association of Family Physician of India

2020
LIFE MEMBER

 Global partnership for zero leprosy

2019
LIFE MEMBER

British Pharmacological society

2018
LIFE MEMBER

 American college of clinical Pharmacology

2018
ANNUAL MEMBER

NATIOANL ACADEMY OF MEDICAL SCIENCES

2016
life member

 Indian Association of Leprologist.

2014
LIFE MEMBER

 Association of physiologist and pharmacologist of India.

2014
LIFE MEMBER

 International Society for Infectious Diseases.

2014
LIFE MEMBER

 WHO –TDR (Tropical Disease Research) SCIENTISTS List.

2014
LIFE MEMBER

Bio

clinical Pharmacology, Infectious disease, Diabetology, Clinical Research, Trials, Pharmacogenomics, leprosy

Personal Details

  • Male
  • Assistant Professor , All India Institute of Medical Sciences (AIIMS), Raipur
  • R NO 2220, DEPARTMENT OF PHARMACOLOGY, II ND FLOOR MEDICAL COLLEGE BUILDING AIIMS RAIPUR
PhD
Other Institute 2024
MBA
Periyar University 2020
DNB
Other Institute 2016
PG DIPLOMA DIABETOLOGY
Other Institute 2015
MD
Other Institute 2013
MBBS
Madurai Medical College 2009
Assistant Professor Oct 2018 – Present
All India Institute of Medical Sciences (AIIMS), Raipur
Senior Medical Officer Sep 2013 – Oct 2018
Ministry of Health and Family Welfare, Government of India, New Delhi

Related Profiles

Experts (5849+)

View All
Abhishek

Mr Abhishek Agarwal

Assistant Professor

Preeti

Dr Preeti Sharma

Assistant Professor

Pavithra

Pavithra Velayutham

Assistant Professor

Mahaboob

Dr Mahaboob Basha

Physical Director

HIBA

HIBA -

Assistant Professor

Muskan

Dr Muskan Jain (PT)

Assistant Professor

Shalini

Ms Shalini Saini

Assistant Professor

Organisations (13+)

View All

Co-Authors (1)

Anil Kumar

Dr Anil Kumar Sharma

All India Institute of Medical Sciences (AIIMS), Raipur

Scholarly Work

Efficacy of sulfonylurea’s in patients with polymorphism in KCNJ11-ABCC8 genetic locus: A prospective cohort study in Chhattisgarh Type 2 Diabetic Mellitus patients.

Funding Agency: AIIMS RAIPUR

PI

500,000

2021 - Ongoing

Ongoing
A prospective, multi-centric, open-labeled, phase-IV study to assess safety and efficacy of LYFAQUIN™ (centhaquine citrate) as a resuscitative agent for hypovolemic shock to be used as an adjuvant to standard treatment of shock

Funding Agency: PHARMAZZ

PI

1,700,000

2021 - Ongoing

Ongoing
Current status of clinical research in COVID-19 using artificial intelligence techniques: A registry-based audit

Funding Agency: Non funded IM AIIMS RAIPUR

PI

NA

2021 - Ongoing

Ongoing
Effect of CYP2C19 and P2Y12 genetic polymorphisms on platelet aggregation in patients on treatment with clopidogrel in Chhattisgarh Population

Funding Agency: CCOST

PI

500,000

2020 - Ongoing

Ongoing
A multicenter, single arm, phase IV clinical trial to evaluate the safety andefficacy of Itolizumab for the treatment of cytokine release syndrome (CRS)in moderate to severe acute respiratory distress syndrome (ARDS) patients due to COVID-19.

Funding Agency: PHARMA COMPANY

CO PI

1,500,000

2020 - Ongoing

Ongoing
Randomized control trials (RCTs) in stigmatized disease “leprosy” – A Compliance CONSORT CHECKLIST

Funding Agency: Non funded IM AIIMS RAIPUR

PI

NA

2020 - Ongoing

Ongoing
HCQ in Indian Population critical Review

Funding Agency: Non funded IM AIIMS RAIPUR

PI

NA

2020 - Ongoing

Ongoing
Molecular docking of AYUSH and modern medication in COVID

Funding Agency: Non funded IM AIIMS RAIPUR

PI

NA

2020 - Ongoing

Ongoing
Hydroxychloroquine + Azithromycin study In COVID 19

Funding Agency: Non funded IM AIIMS RAIPUR

PI

NA

2020 - Ongoing

Ongoing
OpenSurvey of Paediatric Medication Redosing Practices after vomiting in tertiary care hospital in India

Funding Agency: Non funded IM AIIMS RAIPUR

PI

NA

2019 - Ongoing

Ongoing
CPY2C19 distribution in the Central Indian population

Funding Agency: AIIMS RAIPUR

PI

400,000

2019 - Ongoing

Ongoing
Drug utilization study in AIIMS Raipur

Funding Agency: Non funded IM AIIMS RAIPUR

CO PI

NA

2019 - Ongoing

Ongoing
No Data Found

There is currently nothing to display here.

No Data Found

There is currently nothing to display here.

Scholarly Publications

Can HCQ Be Considered a “Safe Weapon” for COVID-19 in the Indian Population?

Open Access
article
Authors: Thangaraju, Pugazhenthan and Venkatesan, Nanditha and Venkatesan, Sajitha and Gurunthalingam, Meenalotchini Prakash and Thangaraju, Eswaran

Single-dose rifampicin: What current World Health Organization guidelines emphasis and practical special attention?

Open Access
article
Authors: Thangaraju, Pugazhenthan and Venkatesan, Sajitha and others

Prerequisite of doing clinical trial with drugs in COVID-19 patients: Situational experience

Open Access
article
Authors: Thangaraju, Pugazhenthan and Jindal, Atul

A Nonsystematic Review on Risankizumab: a Novel Drug Recently Approved for Moderate to Severe Psoriasis

Open Access
article
Authors: Varthya, Shoban Babu and Thangaraju, Pugazhenthan and Venkatesan, Sajitha and Vijayakumar, AR and Thangaraju, Eswaran

Nutritional status and morbidity profile of children with leprosy contact in a rural community

Open Access
article
Authors: Venkatakrishnan, Yegnaraman and Thangaraju, Pugazhenthan and Jeganathan, Sathya and Sankaran, Suresh K and Kannan, Rajkumar

Medical residents: Research and publication priorities/confusions.

Open Access
article

COVID-19: Older drugs for a novel disease—Chloroquine, hydroxychloroquine, and possible Pentoxifylline—set to start the second innings?

Open Access
article
Authors: Thangaraju, Pugazhenthan and Gurunthalingam, Meenalotchini P and Varthya, Shobanbabu and Venkatesan, Sajitha and Thangaraju, Eswaran and others

Curcumin and fungal infection--commonly available herbs for common female infection

Open Access
article
Authors: Varthya, Shoban Babu and Thangaraju, Pugazhenthan and Venkatesan, Sajitha